Neither CD8+PD-1+CD161+ T cells in tumor nor CD8+PD-1+CD161− T cells in non-tumor adjacent tissues showed potential correlation with prognosis (Fig. 4b, c). This evidence concerns the gene KLRB1 and neoplasm.